17
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Low-dose Leukocyte Interferon-α Therapy in Dialysed Patients with Chronic Hepatitis C

, , , &
Pages 141-144 | Accepted 24 Apr 1998, Published online: 26 Aug 2008

References

  • Pol S., Legendre C. Viral hepatitis in hemodialysis and renal transplantation patients. Nephrotoxic 1994; 15: 191–1951. Pol S., Legendre C. Viral hepatitis in hemodialysis and renal transplantation patients. Nephrotoxic 1994; 15: 191–195
  • Umlauft R., Weiss G., Urbanek M., Haun M., Weyrer K., Koenig P., Vogel W., Griinewald K. Kinetics of HCV-viremia in interferon alpha treated and untreated HCV-infected hemodialysis patients. Hepatology 1994; 20(Suppl 4, Pt 2), Abstract No. 2802. Umlauft R., Weiss G., Urbanek M., Haun M., Weyrer K., Koenig P., Vogel W., Griinewald K. Kinetics of HCV-viremia in interferon alpha treated and untreated HCV-infected hemodialysis patients. Hepatology 1994; 20(Suppl 4, Pt 2), Abstract No. 280
  • Ellis M. E., Alfurayh O., Halim M. A., Sieck J. O., Ali M. A., Bernvil S. S., Ali H., Barri Y., Ayub A., al-Fadda M. Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha. J. Hepatol. 1993; 18: 210–2163. Ellis M. E., Alfurayh O., Halim M. A., Sieck J. O., Ali M. A., Bernvil S. S., Ali H., Barri Y., Ayub A., al-Fadda M. Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha. J. Hepatol. 1993; 18: 210–216
  • Sungur C., Akpolat T., Ozcebe O., Yasavul U., Turgan C., Caglar S. Hematologic profile of dialysis palients receiving alpha-interferon and erythropoietin concomitantly. (Letter). Nephron 1994; 67: 4494. Sungur C., Akpolat T., Ozcebe O., Yasavul U., Turgan C., Caglar S. Hematologic profile of dialysis palients receiving alpha-interferon and erythropoietin concomitantly. (Letter). Nephron 1994; 67: 449
  • Fernandez J. L., Rendo P., del Pino N., Viola L. A double-blind controlled trial of recombinant interferon alfa in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the study of HCV infection. J. Viral Hepat. 1997; 4: 113–1195. Fernandez J. L., Rendo P., del Pino N., Viola L. A double-blind controlled trial of recombinant interferon alfa in hemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the study of HCV infection. J. Viral Hepat. 1997; 4: 113–119
  • Taltavull Casanovas T., Baliellas C., Sesé E., Cervantes X., Perellò A., Benasco C., Andrés E., Gonzàlez M. T., Gil-Vernel S., Casanova A., Casais L. A. Chronic HCV infection in HD (hemodialysed) candidates to KT (kidney transplant). Influence of HCV genotypes on response to IFN (interferon). Hepatology 1995; 22(Suppl 4, Pi 2), Abstract No. 11756. Taltavull Casanovas T., Baliellas C., Sesé E., Cervantes X., Perellò A., Benasco C., Andrés E., Gonzàlez M. T., Gil-Vernel S., Casanova A., Casais L. A. Chronic HCV infection in HD (hemodialysed) candidates to KT (kidney transplant). Influence of HCV genotypes on response to IFN (interferon). Hepatology 1995; 22(Suppl 4, Pi 2), Abstract No. 1175
  • Hirsch M. S., Tolkoff-Rubin N. E., Kelly A. P., Rubin R. H. Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis. J. Infect. Dis. 1983; 148: 3357. Hirsch M. S., Tolkoff-Rubin N. E., Kelly A. P., Rubin R. H. Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis. J. Infect. Dis. 1983; 148: 335
  • Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274–2788. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274–278

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.